|
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
|
|
|
Item 7.01. |
Regulation FD Disclosure.
|
Item 9.01. |
Financial Statements and Exhibits.
|
Exhibit Number
|
Exhibit Title or Description
|
|
Press Release, dated December 6, 2023
|
||
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
GYRE THERAPEUTICS, INC.
|
||
Date: December 6, 2023
|
By:
|
/s/ Charles C. Wu, Ph.D.
|
Name:
|
Charles C. Wu, Ph.D.
|
|
Title:
|
Chief Executive Officer
|
Company Name:
|
GNI Group Ltd.
|
|
Representative:
|
Director, Representative Executive Officer,
President and CEO
Ying Luo, PhD
|
|
(Security Code: 2160, TSE Growth)
|
||
Contact Person:
|
Chief Financial Officer
Toshiya Kitagawa
|
|
(TEL. 03-6214-3600)
|
1) |
Update of Other Income
|
2) |
Update of Forecast
|
1. |
The differences between the previous and the updated 2023 consolidated
earnings forecast for full-year 2023 (January 1, 2023 – December 31, 2023)
|
|
Revenue
|
|
Operating
profit
|
|
Profit before
tax
|
|
Profit for
the year
|
|
Profit
attributable to
owners of the
parent
|
|
Basic earnings
per share
|
||
|
(JPY Million)
|
|
(JPY Million)
|
|
(JPY Million)
|
|
(JPY Million)
|
|
(JPY Million)
|
|
(JPY)
|
||
|
Previous Forecast (A)
|
|
26,267
|
|
7,280
|
|
6,430
|
|
4,351
|
|
2,005
|
|
42.20
|
|
Revised Forecast (B)
|
|
26,300
|
|
15,744
|
|
14,865
|
|
11,234
|
|
8,971
|
|
180.42
|
|
Difference (B-A)
|
|
33
|
|
8,464
|
|
8,435
|
|
6,883
|
|
6,966
|
|
-
|
|
Difference in ratio (%)
|
|
0.1%
|
|
116.3%
|
|
131.2%
|
|
158.2%
|
|
347.4%
|
|
-
|
|
(Reference) 2022 Actual
|
|
17,418
|
|
1,377
|
|
767
|
|
(868)
|
|
388
|
|
8.19
|
2. |
Reasons for the differences
|